By Michael SusinGSK said it reached a confidential settlement with plaintiff Ronald Kimbrow, resolving a case related to its discontinued heartburn medicine Zantac in the Illinois state court, without disclosing further details. The British pharmaceutical company on Monday said it will continue to vigorously defend itself and manage this litigation in the best interests of the company and shareholders. "GSK does not admit any liability in this settlement. The case will now be dismissed as to GSK," it added. Write to Michael Susin at michael.susin@wsj.com(END) Dow Jones Newswires07-29-24 0349ET

Source: Wall Street Journal July 29, 2024 07:54 UTC